✓ A synthetic replacement of vasopressin, the hormone that reduces urine production
✓ A new low-dose formulation of desmopressin characterized by the addition of cyclopentadecanolide, an excipient that enhances the bioavailability of the drug
✓ First & still the only treatment of Nocturia due to Nocturnal Polyuria approved by the FDA in 2017
